Percutaneous Coronary Intervention Clinical Trials

70 recruitingLast updated: June 18, 2026

There are 70 actively recruiting percutaneous coronary intervention clinical trials across 24 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2. Top locations include Beijing, Beijing Municipality, China, Seoul, South Korea, Lanzhou, Gansu, China. Updated daily from ClinicalTrials.gov.


Percutaneous Coronary Intervention Trials at a Glance

70 actively recruiting trials for percutaneous coronary intervention are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 31 trials, with the heaviest enrollment activity in Beijing, Seoul, and Lanzhou. Lead sponsors running percutaneous coronary intervention studies include Xijing Hospital, Genoss Co., Ltd., and China National Center for Cardiovascular Diseases.

Browse percutaneous coronary intervention trials by phase

Treatments under study

About Percutaneous Coronary Intervention Clinical Trials

Looking for clinical trials for Percutaneous Coronary Intervention? There are currently 46 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Percutaneous Coronary Intervention trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Percutaneous Coronary Intervention clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 70 trials

Recruiting
Phase 4

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University6,000 enrolled103 locationsNCT06909565
Recruiting
Phase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Atrial FibrillationAcute Coronary SyndromeAntithrombotic Therapy+1 more
Medical University of Gdansk1,194 enrolled1 locationNCT04695106
Recruiting
Not Applicable

Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study

Depressive DisorderPercutaneous Coronary Intervention (PCI)Acute Coronary Syndrome (ACS)+5 more
Jing Han120 enrolled1 locationNCT07454070
Recruiting
Not Applicable

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

Coronary Artery DiseaseInterventional CardiologyMechanical Circulatory Support+1 more
Supira Medical358 enrolled14 locationsNCT07296744
Recruiting

Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography

Chronic Coronary SyndromeAngina, StablePercutaneous Coronary Intervention (PCI)+1 more
Fundacion Investigacion Interhospitalaria Cardiovascular246 enrolled5 locationsNCT07638137
Recruiting
Not Applicable

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Diffuse Coronary Artery Disease
University Hospital, Geneva150 enrolled3 locationsNCT06710210
Recruiting

Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction

Coronary Arterial Disease (CAD)Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Azienda Ospedaliera di Bolzano1,500 enrolled1 locationNCT06910436
Recruiting
Not Applicable

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

BleedingPercutaneous Coronary InterventionCoronary Angiography+2 more
University Hospital, Strasbourg, France550 enrolled1 locationNCT06890312
Recruiting

OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
Albert Schweitzer Ziekenhuis, Netherlands117 enrolled1 locationNCT06919562
Recruiting
Phase 4

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting
Phase 3

Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more
Cardiocentro Ticino355 enrolled1 locationNCT07582835
Recruiting
Not Applicable

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

AnesthesiologyAnalgesiaPercutaneous Coronary Intervention+2 more
Istanbul University - Cerrahpasa100 enrolled1 locationNCT06576128
Recruiting
Not Applicable

Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone

Percutaneous Coronary Intervention (PCI)Acute Coronary Syndrome (ACS)Drug-coated Balloon+1 more
Ceric Sàrl2,256 enrolled1 locationNCT07038408
Recruiting
Not Applicable

Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).

Chronic Coronary SyndromeCoronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)+6 more
Spanish Society of Cardiology50 enrolled6 locationsNCT06736665
Recruiting
Not Applicable

ELEVATE High-Risk PCI Pivotal Study

High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Magenta Medical Ltd.290 enrolled29 locationsNCT07001332
Recruiting
Not Applicable

Video-based Intervention to Reduce Anxiety in Patients Undergoing Elective PCI

Coronary Artery DiseaseProcedural AnxietyPercutaneous Coronary Intervention Patients
Tan Tock Seng Hospital144 enrolled1 locationNCT07485088
Recruiting

Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients

Coronary Artery DiseasePercutaneous Coronary InterventionTranscatheter Aortic Valve Implantation (TAVI)+2 more
National Taiwan University Hospital157 enrolled1 locationNCT07469397
Recruiting
Phase 4

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
J.P.S Henriques300 enrolled1 locationNCT06916520
Recruiting
Not Applicable

IVUS-FFR Accuracy for Coronary Stenosis

Percutaneous Coronary InterventionIntravenous UltrasoundCoronary Physiology
China National Center for Cardiovascular Diseases292 enrolled1 locationNCT07446023
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Cardiorespiratory FitnessAcute Myocardial InfarctionAngina, Stable+3 more
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275